Emissary - A Contract Research Organization (CRO) accelerating clinical research trials Emissary International is a contract clinical research organization (CRO). http://www.emissary.com/16-clinical-research-articles/focus-on-clinical-investigators-a-coordinators 2017-10-01T05:09:30-05:00 Emissary.com smayo@emissary.com Joomla! - Open Source Content Management Surviving an FDA Inspection of Your Clinical Trial Site 2008-03-12T11:39:32-05:00 2008-03-12T11:39:32-05:00 http://www.emissary.com/16-clinical-research-articles/focus-on-clinical-investigators-a-coordinators/42-fda-inspection <p><span>The Investigational New Drug (IND) regulations went into effect in 1963. Ever since, the U.S. Food and Drug Administration (FDA) has conducted clinical site inspections under what is known as the Bioresearch Monitoring Program. The agency now conducts several hundred inspections of clinical investigators annually to obtain compliance with the regulations and to ensure that data submitted to the FDA are substantiated by appropriate records. </span></p> <p class="feed-readmore"><a target="_blank" href ="">Read More...</a></p> <p><span>The Investigational New Drug (IND) regulations went into effect in 1963. Ever since, the U.S. Food and Drug Administration (FDA) has conducted clinical site inspections under what is known as the Bioresearch Monitoring Program. The agency now conducts several hundred inspections of clinical investigators annually to obtain compliance with the regulations and to ensure that data submitted to the FDA are substantiated by appropriate records. </span></p> <p class="feed-readmore"><a target="_blank" href ="">Read More...</a></p> Physicians find clinical research brings income and treatment options 2002-08-02T00:01:15-05:00 2002-08-02T00:01:15-05:00 http://www.emissary.com/16-clinical-research-articles/focus-on-clinical-investigators-a-coordinators/57-clinical-research-benefits-for-physicians <p><span style="line-height: 1.3em;">Trying their patients: practitioners find clinical research projects, chosen well, can create extra income and widen treatment options.</span></p> <p class="browsecontent"> </p> <p>Phase III clinical research has the potential for eye-catching margins, but private practitioners who enter the, field with that motive seldom stay. The reason? Financial returns don't come easily, and the process is fraught with opportunities for failure.</p> <p class="feed-readmore"><a target="_blank" href ="">Read More...</a></p> <p><span style="line-height: 1.3em;">Trying their patients: practitioners find clinical research projects, chosen well, can create extra income and widen treatment options.</span></p> <p class="browsecontent"> </p> <p>Phase III clinical research has the potential for eye-catching margins, but private practitioners who enter the, field with that motive seldom stay. The reason? Financial returns don't come easily, and the process is fraught with opportunities for failure.</p> <p class="feed-readmore"><a target="_blank" href ="">Read More...</a></p>